| Autor: |
Piñana, José Luis, López-Corral, Lucia, Martino, Rodrigo, Montoro, Juan, Vazquez, Lourdes, Pérez, Ariadna, Martin-Martin, Gabriel, Facal-Malvar, Ana, Ferrer, Elena, Pascual, María-Jesús, Sanz-Linares, Gabriela, Gago, Beatriz, Sanchez-Salinas, Andrés, Villalon, Lucia, Conesa-Garcia, Venancio, Olave, Maria T, López-Jimenez, Javier, Marcos-Corrales, Sara, García-Blázquez, Marta, Garcia-Gutiérrez, Valentín, Hernández-Rivas, José Ángel, Saus, Ana, Espigado, Ildefonso, Alonso, Carmen, Hernani, Rafael, Solano, Carlos, Ferrer-Lores, Blanca, Guerreiro, Manuel, Ruiz-García, Montserrat, Muñoz-Bellido, Juan Luis, Navarro, David, Cedillo, Angel, Sureda, Anna, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Popis: |
This is a multicenter prospective observational study that included a large cohort (n = 397) of allogeneic (allo-HSCT; (n = 311) and autologous (ASCT) hematopoietic stem cell transplant (n = 86) recipients who were monitored for antibody detection within 3-6 weeks after complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination from February 1, 2021, to July 20, 2021. Most patients (n = 387, 97.4%) received mRNA-based vaccines. Most of the recipients (93%) were vaccinated more than 1 year after transplant. Detectable SARS-CoV-2-reactive antibodies were observed in 242 (78%) of allo-HSCT and in 73 (85%) of ASCT recipients. Multivariate analysis in allo-HSCT recipients identified lymphopenia |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
